Skip to main content

Catherine Mackey

Cypher Genomics has appointed Catherine 'Kitty' Mackey to its scientific advisory board. Mackey is currently the CEO of Cyprus Therapeutics. Previously, she was senior vice president of worldwide research and development for Pfizer and director of Pfizer La Jolla laboratories. She also worked as a member of the executive team at Dekalb Genetics before the company was bought by Monsanto.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.